Stay updated on PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page.

Latest updates to the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry (v3.7.0) has been added to the history, signaling an update to the study page; the older revision (v3.6.6) is removed from the current history view.SummaryDifference0.1%

- Check37 days agoChange DetectedThe record history now shows a new revision entry, updating the page from v3.6.5 to v3.6.6. This reflects a minor platform update to the ClinicalTrials.gov interface rather than changes to study data.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history now shows a new revision entry 'Revision: v3.6.5' and drops the previous 'Revision: v3.6.4', updating the page's revision timeline. This reflects an administrative update to the page's version history rather than changes to study data.SummaryDifference0.1%

- Check73 days agoChange DetectedA new study record revision (v3.6.4) was added to the history, and the previous revision (v3.6.3) was removed from the list. This reflects an update to the record's version history.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision label in the page footer updated from v3.6.2 to v3.6.3. This reflects a minor platform update to the record history page and does not change the trial data or visible content.SummaryDifference0.1%

- Check102 days agoChange DetectedThe page’s revision label changed from v3.6.0 to v3.6.2, indicating a minor version update on the study history page.SummaryDifference0.1%

Stay in the know with updates to PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001 Plus LAG525 in Solid and Hematologic Malignancies Clinical Trial page.